Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Shield Therapeutics plc market cap is $45.36M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Shield Therapeutics plc 52 week high is $0.151 as of November 30, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Shield Therapeutics plc 52 week low is $0.072 as of November 30, 2023.
Shield Therapeutics plc stock price today is $0.072.
Shield Therapeutics plc stock price yesterday was $0.074.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Shield Therapeutics plc’s P/E ratio is -0.46.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Shield Therapeutics plc P/B ratio is 1.8942.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Shield Therapeutics plc's EBITDA is -1.69.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Shield Therapeutics plc 50-day moving average is $0.0905.
Shield Therapeutics plc has 27 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.